False Claims Act – Page 12 – Policy & Medicine

Pfizer Pays Millions to Resolve Co-Pay Allegations – Settlement and Corporate Integrity Agreement

Fresenius Provides Insight As to Why It Terminated Acquisition of Akorn, Inc.

Off-Label Promotion: Tennessee Becomes Second State to Allow Pharmaceutical Companies to Engage in Truthful Promotion of Off

McKesson Accused of Illegally Handling Cancer Medications

The Escobar Hurdle – False Claims, Materiality, and Dismissal

Alere Settles False Claims Act Allegations for $33.2 Million

Taking Center Stage – Washington State’s Medicaid Fraud Control Unit, the False Claims Act and Celgene

Fresenius to the U.S. Government: When It Comes to the FCA, You Snooze You Lose

False Claims Act Mid-Year Review: Significant Life Science Settlements, Post-Escobar Developments & Industry Round Up

FDA Warns Cipher Over “Misleading” Marketing Materials